CRESTSyndrom
CREST syndrome, also known as limited cutaneous systemic sclerosis, is a form of systemic sclerosis characterized by the five features encoded in the acronym CREST: Calcinosis, Raynaud phenomenon, Esophageal dysmotility, Sclerodactyly, and Telangiectasia. It is considered a limited subset of the disease, with skin involvement mainly on the face and distal extremities, and a relative emphasis on vascular and mucosal manifestations rather than widespread skin thickening.
Pathophysiology centers on autoimmune processes with microvascular injury and progressive fibrosis that can affect the skin
Diagnosis is clinical, supported by serology and imaging. The presence of the CREST components suggests the
Management is multidisciplinary and aimed at relieving symptoms, preserving function, and monitoring for organ involvement. Treatments
Prognosis is generally better than in diffuse systemic sclerosis, but CREST carries risks of vascular complications